Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

Back

ESC Professional Premium Access

Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

Session: Registries, observational, and other studies on atrial fibrillation

Topic: Clinical

Speaker: Associate Professor D. Conen (Hamilton, CA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor David Conen

Population Health Research Institute, Hamilton (Canada)

5 presentations

1 follower

5 more presentations in this session

Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?

Speaker: Professor R. Providencia (London, GB)

Access

Slides

Video

Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study

Speaker: Doctor M. Badoz (Besancon, FR)

Access

Slides

Video

A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis

Speaker: Doctor T. Stegmann (Leipzig, DE)

Access

Slides

Video

Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III

Speaker: Doctor B. Corica (Modena, IT)

Access

Slides

Video

Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry

Speaker: Professor J. Brachmann (Coburg, DE)

Access

Slides

Video

Access the full session

Registries, observational, and other studies on atrial fibrillation

Speakers: Associate Professor D. Conen, Professor R. Providencia, Doctor M. Badoz, Doctor T. Stegmann, Doctor B. Corica...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources